Dr. Adrese Kandahari is a board-certified oncologist and hematologist at The Angeles Clinic and Research Institute in West LA. Dr. Kandahari specializes in the full breadth of oncologic and hematologic conditions, incorporating cutting-edge research and modalities to create specialized care plans. Dr. Kandahari practices under the paradigm that tumor and patient biology are unique in every case, prioritizing collaborative and individualized patient care.
Dr. Kandahari’s medical training reflects a strong foundation in both the science and practice of oncology and hematology. He earned his medical degree from the University of Virginia School of Medicine, one of the nation’s leading academic medical institutions, before completing his residency at Methodist Dallas Medical Center. He went on to pursue specialized fellowship training in hematology and oncology at Westchester Medical Center, an affiliate of New York Medical College, where he deepened his expertise in the diagnosis and treatment of complex blood disorders and malignancies.
In his clinical practice, Dr. Kandahari focuses on a wide range of high-need areas within oncology, including thoracic oncology and non-melanoma skin cancers. He has particular expertise in targeted therapy and immunotherapy, treatment approaches that harness the body’s own immune system or precisely target the molecular drivers of cancer to improve outcomes while minimizing side effects. His practice also encompasses the treatment of upper gastrointestinal, pancreatic, bile duct, and kidney cancers, as well as lung and breast cancers, allowing him to care for patients across a broad and often challenging spectrum of malignancies.
Guided by the understanding that no two patients or tumors are alike, Dr. Kandahari brings a collaborative, research-informed approach to every case. He works closely with patients to develop individualized treatment plans that reflect the latest advances in oncologic and hematologic care, combining clinical rigor with a personalized approach to support patients throughout their treatment journey.